The Latest Cardiac and Vascular News
Towards a new standard for device indication: Implantation for temporary or permanent use Easy removal with a beating heart without damage to the myocardium 30 days after implantation Normal heart functioning 60 days after explantation Completely sealed operation with dedicated implant fixation system Quick recovery and short hospital stay Autonomy […]
A major step and a critical milestone achieved prior to First In Human clinical trials FineHeart’s TET is a system with no percutaneous driveline that transfers energy through the skin to charge the ICOMS pump battery TET is rapidly implantable (less than 15 mins) and will give patients autonomy The […]
The ICOMS device is the first destination therapy that restores natural heart pumping capacity This successful milestone is a major step towards first in human clinical trials BORDEAUX, France–(BUSINESS WIRE)–FineHeart, SA, a preclinical-stage medical device company developing an Implantable Cardiac Output Management System (ICOMS) to address the unmet need of […]
First destination therapy that restores natural heart pumping capacity; potential game changer for more than 200,000 untreated severe heart failure patients per year BORDEAUX, France–(BUSINESS WIRE)–FineHeart, a French medical device company, today announced the success of a seven-day preclinical study to evaluate its Implantable Cardiac Output Management System (ICOMS), the […]
BORDEAUX, France–(BUSINESS WIRE)–FineHeart today announced that it has been named by FierceMedTech as one of 2018’s Fierce 15 med tech companies, designating it as one of the most promising private med tech companies in the industry. FineHeart’s technology, the ICOMS (Implantable Cardiac Output Management System), is dedicated to the treatment of severe heart […]
